Genzyme and Osiris Sign Deal for First-in-Class Adult Stem Cell Products

By Taskin Ahmed

Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)

Published: 4 Nov-2008

DOI: 10.3833/pdr.v2008.i102.110     ISSN: 1756-7874

Section: Licensing



Osiris Therapeutics and Genzyme struck a marketing deal for two adult stem cell treatments, Prochymal and Chondrogen, both of which are in clinical trials...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details